Vermillion & White Wealth Management Group’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-56
Closed -$7.28K 539
2025
Q4
$7.28K Hold
56
﹤0.01% 360
2025
Q3
$6.03K Hold
56
﹤0.01% 388
2025
Q2
$5.17K Buy
56
+4
+8% +$314 ﹤0.01% 364
2025
Q1
$4.61K Buy
+52
New +$4.51K ﹤0.01% 366

Other funds holding WGS

Vermillion & White Wealth Management Group's WGS Position: Q1 2026 in Review

Vermillion & White Wealth Management Group sold out of GeneDx Holdings (WGS) in Q1 2026, closing a stake of 56 shares — an estimated $7.28K sold.

Vermillion & White Wealth Management Group first reported a position in WGS in Q1 2025 and held it in 4 quarters. The position peaked at $7.28K in Q4 2025. 240 funds tracked by Wall St. Rank hold WGS as of Q1 2026.

  • Vermillion & White Wealth Management Group reported no remaining GeneDx Holdings position as of Q1 2026 after selling out during the quarter.
  • Vermillion & White Wealth Management Group sold 56 GeneDx Holdings shares in Q1 2026, an estimated $7.28K.
  • Vermillion & White Wealth Management Group first reported a position in GeneDx Holdings in Q1 2025 and held it in 4 quarters.
  • Vermillion & White Wealth Management Group's GeneDx Holdings position peaked at $7.28K in Q4 2025.
  • 240 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2026.

Based on Vermillion & White Wealth Management Group's 13F filing for Q1 2026, filed 14 May 2026.